The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


PegIntron



Merck Sharp & Dohme BVEU/1/00/131/008

Main Information

Trade NamePegIntron
Active SubstancesPeginterferon alfa-2b
Dosage FormPowder and solvent for solution for injection
Licence HolderMerck Sharp & Dohme BV
Licence NumberEU/1/00/131/008

Group Information

ATC CodeL03AB Interferons
L03AB10 peginterferon alfa-2b

Status

License statusWithdrawn
Withdrawn Date21/04/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back